← CRISPR Therapeutics
What podcasts say about CRISPR Therapeutics
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about CRISPR Therapeutics
1 statement · 1 mixed
CRISPR Therapeutics is interesting long term but unattractive for 2026.
“Long term, very interesting. Short term, 2026, not interested.”
Open the episode · RBA raises rates again, Pimp my Portfolio with Henry Jennings & we review the community portfolioListen at 31:35
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.